Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in UZ Leuven - Campus Gasthuisberg.

During the past decade, UZ Leuven - Campus Gasthuisberg conducted 140 clinical trials. In the 10-year time frame, 140 clinical trials started and 42 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 32 clinical trials were completed. i.e. 47.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UZ Leuven - Campus Gasthuisberg" #1 sponsor was "Eli Lilly and Company" with 24 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 24 trials sponsored, "Amgen" with 14 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 13 trials sponsored and "Pfizer" with 13 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 69 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UZ Leuven - Campus Gasthuisberg" #1 collaborator was "Eli Lilly and Company" with 6 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "ADIR, a Servier Group company" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 55 trials.

According to Clinical.Site data, the most researched conditions in "UZ Leuven - Campus Gasthuisberg" are "Cystic Fibrosis" (13 trials), "Ulcerative Colitis" (8 trials), "Metastatic Breast Cancer" (6 trials), "Breast Cancer" (5 trials) and "Crohn's Disease" (5 trials). Many other conditions were trialed in "UZ Leuven - Campus Gasthuisberg" in a lesser frequency.

Most popular intervention types in "UZ Leuven - Campus Gasthuisberg" are "Drug" (130 trials), "Other" (24 trials), "Device" (15 trials), "Biological" (9 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "IVA" (13 trials), "ELX/TEZ/IVA" (8 trials), "Abemaciclib" (5 trials) and "TEZ/IVA" (5 trials). Other intervention names were less common.

The vast majority of trials in "UZ Leuven - Campus Gasthuisberg" are 146 trials for "All" genders, 20 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "UZ Leuven - Campus Gasthuisberg". undefined are not yet recruiting, 45 are recruiting, 34 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 70 completed trials in UZ Leuven - Campus Gasthuisberg, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in UZ Leuven - Campus Gasthuisberg, 26 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 16 trials that are defined as “Not Applicable".